The Penicillins and Streptomycins market in South Africa stood at 142.32 million USD in 2023. The market witnessed fluctuations over the past years, peaking at 171.08 million USD in 2015 before a notable decline. The last two years saw year-on-year variations of -0.67% and -0.66%, respectively, highlighting stability around the 142 million USD mark. Over the past 5 years, the average annual variation (CAGR) was -0.0042%, indicating near stagnation.
Forecasts predict a continued downward trend, with an anticipated CAGR of -0.52% through 2028, expected to bring the market size to 137.71 million USD by then.
Future trends to watch for:
- Advancements in generic drug production and their potential market impacts.
- Government policies and healthcare reforms affecting antibiotic use.
- Emerging resistance to antibiotics and its influence on market demand.
